Roxanne Nelson, RN

Not just what, but when: Neoadjuvant pembrolizumab in melanoma

Publish date: September 14, 2022

Neoadjuvant pembrolizumab followed by pembrolizumab improves event-free survival in resectable melanoma.

Publish date: September 14, 2022

The treatment of patients with melanoma who do not respond to or progress after receiving immunotherapy is “challenging and represents an unmet...

Publish date: April 30, 2022

An accurate diagnosis of the underlying cause of discomfort is key to appropriate management of knee and shoulder pain.

Publish date: February 25, 2022

Both globally and in the U.S., children have lost parents and other caregivers to COVID-19, and may be left with no one to care for them.

Publish date: February 17, 2022

The expanded Medicare recommendation will address racial disparities associated with lung cancer.

Publish date: February 3, 2022

The committee also recommended approval of a biosimilar product for pegfilgrastim.

Publish date: January 7, 2022

Therapeutic aquatic exercise proved more beneficial than physical therapy in relieving symptoms and disability caused by chronic back pain.

Publish date: December 20, 2021

Experts and imaging center staff give recommendations regarding the timing of getting boosters and mammograms.

Publish date: October 5, 2020

Combination nivolumab and ipilimumab has now been approved as first-line treatment in mesothelioma.